Literature DB >> 4294135

New 1,2-disubstituted benzimidazoles with high inhibiting effects on poliovirus replication.

D G O'Sullivan, D Pantic, A K Wallis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4294135     DOI: 10.1007/bf02154123

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  2 in total

1.  PROTECTION OF POLIOVIRUS-INFECTED TISSUE-CULTURE CELLS USING THE 1-BENZYL, 1-PENTYL AND 1-ISOPROPYL DERIVATIVES OF 2-(ALPHA-HYDROXYBENZYL)-BENZIMIDAZOLE.

Authors:  D G O'SULLIVAN; D PANTIC; A K WALLIS
Journal:  Nature       Date:  1964-07-25       Impact factor: 49.962

2.  PROTECTION OFFERED TO POLIOVIRUS-INFECTED TISSUE-CULTURE CELLS BY METHOXY- AND HYDROXY-METHYL COMPOUNDS RELATED TO 2-BENZYLBENZIMIDAZOLE.

Authors:  D G O'SULLIVAN; D PANTIC; A K WALLIS
Journal:  Nature       Date:  1965-01-16       Impact factor: 49.962

  2 in total
  7 in total

1.  Antiviral properties of 1-allyl and 1-crotyl derivatives of 2-( -hydroxybenzyl) benzimidazole.

Authors:  D G O'Sullivan; C M Ludlow
Journal:  Experientia       Date:  1972-08-15

2.  [Antiviral activity of imidazole derivatives. IV. Sensitivity of different viruses].

Authors:  M Tonew; E M Tonew; P Zöpel
Journal:  Arch Gesamte Virusforsch       Date:  1971

3.  [Antiviral activity of imidazole derivatives. I. Inhibition of multiplication of mengovirus in FL cells].

Authors:  M Tonew; E M Tonew
Journal:  Arch Gesamte Virusforsch       Date:  1971

4.  The high activity of fluorohydroxybenzylbenzimidazoles against some small RNA-viruses.

Authors:  D G O'Sullivan; C M Ludlow; A K Wallis
Journal:  Experientia       Date:  1971-09-15

5.  Loganin from Mytragyna parvifolia Korth.

Authors:  D G O'Sullivan; D Pantic; A K Wallis
Journal:  Experientia       Date:  1968-12-15

6.  D-5-Chloro-2-(alpha-hydroxybenzyl) benzimidazole and 1-alkyl-5-chloro-2-(alpha-hydroxybenzyl) benzimidazoles as inhibitors of poliovirus multiplication.

Authors:  D G O'Sullivan; D Pantic; A K Wallis
Journal:  Experientia       Date:  1968-07-15

7.  High Throughput Screening Identifies a Novel Compound Protecting Cardiomyocytes from Doxorubicin-Induced Damage.

Authors:  Szabolcs Gergely; Csaba Hegedűs; Petra Lakatos; Katalin Kovács; Renáta Gáspár; Tamás Csont; László Virág
Journal:  Oxid Med Cell Longev       Date:  2015-06-07       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.